GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Exact Sciences Corporation (EXAS) [hlAlert]

Rating:
Buy EXAS
up 287.26 %

Exact Sciences Corporation (EXAS) rated Buy with price target $10 by Auriga U.S.A

Posted on: Tuesday,  May 3, 2011  2:25 PM ET by Auriga U.S.A

Auriga U.S.A rated Buy Exact Sciences Corporation (NASDAQ: EXAS) on 05/03/2011. Previously Auriga U.S.A rated Buy Exact Sciences Corporation (NASDAQ: EXAS) on
03/01/2011., when the stock price was $5.73. Since then, Exact Sciences Corporation has gained 287.26% as of 01/13/2016's recent price of $22.19.
If you would have followed the previous Auriga U.S.A's recommendation on EXAS, you would have gained 287.26% of your investment in 1779 days.

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population. Colorectal cancer, which is the most deadly cancer among non-smokers, is generally curable if detected early. Despite the availability of colorectal cancer screening and diagnostic tests for more than twenty years, the rate of early detection of colorectal cancer remains low, and deaths from colorectal cancer remain high. EXACT Sciences believes its genomics-based technologies would help to enable detection of colorectal cancer so that more people can be effectively treated.

Auriga is committed to providing our clients with market information flow, investment ideas and access to industry experts. We strive to provide value through unique industry knowledge. Our growing research practice is being built with domain experts who have a strong reputation amongst institutional investors. Auriga’s research analysts have also been recognized by numerous industry publications including, The Wall Street Journal and Bloomberg. Our bottom-up fundamental approach is data point driven with a primary focus on growth sectors within the technology and healthcare verticals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/3/2011 2:25 PM Buy
None
7.59 10.00
as of 12/30/2011
1 Week up  0.61 %
1 Month down  -4.35 %
3 Months up  22.47 %
1 YTD up  6.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/1/2011 8:25 AM Buy
None
5.73 10.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy